The University of Southampton
University of Southampton Institutional Repository

Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction

Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction
Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction
Background & Aims: metabolic dysfunction-associated steatotic liver disease (MASLD) and pancreatic steatosis (PS) are interconnected ectopic fat conditions linked to cardiometabolic dysregulation. Their combined effect on the long-term risk of cardiometabolic multimorbidity (CMM; ≥ 2 of diabetes, hypertension, coronary heart disease, and stroke) and cardiac remodelling remains unclear.

Methods: we examined cross-sectional associations between PS and the severity of MASLD histology in a biopsy-proven MASLD cohort from China. Subsequently, using the UK Biobank, we assessed the long-term risk of developing both incident CMM and cardiac structural/functional alterations (via cardiac magnetic resonance [CMR]) associated with single-organ versus dual-organ steatosis. Exploratory proteomic profiling was performed to identify potential molecular pathways.

Results: in the biopsy-proven cohort (n = 482), both continuous pancreatic proton density fat fraction and PS status were associated with severe hepatic steatosis, lobular inflammation, and fibrosis (all p < 0.05). In the UK Biobank cohort (n = 16 408; median follow-up of 5.6 years), the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219–3.322, p = 0.006). Dual-organ steatosis was also associated with marked cardiac alterations, specifically increased left ventricular mass and impaired ventricular function. Proteomics revealed upregulation of lysosomal catabolic and glycosaminoglycan-degrading pathways in dual-organ steatosis compared to single-organ steatosis. Gene Ontology highlighted heparan sulphate proteoglycan catabolism as a hallmark of dual-organ involvement.

Conclusion: PS is associated with greater severity of MASLD histology, and the concomitant involvement of both the liver and pancreas drives a higher risk of CMM and cardiac remodelling.

1478-3223
Lian, Li-You
a1293ae9-9f18-4c6e-bdea-d9831ca94887
Xia, Tianyi
b67c4fe9-9cf1-428e-8edc-7e68bba05a5b
Chen, Zhong-Wei
aa23fe30-344c-45cf-85c8-39295f8e33d7
Wen, Cai-Yun
650f63c3-64d7-4187-9967-95da95ca21b5
Zhou, Xiao-Dong
d36a40bb-d60d-4969-a319-60db45c19cc7
Xiao, Tie
d7fbb1ac-c12e-402d-ba7a-5ab27dac63d9
Targher, Giovanni
23ef21d8-f1cb-4a6a-baf4-b74acce04e91
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Yeo, Yee Hui
8f6198df-37e0-40a5-b44d-049c3f973ee3
Ju, Shenghong
2526c931-d6cb-4559-aac5-a27e965ebbee
Liu, Wen-Yue
1ef2663c-e732-499e-9ec8-2a014c1664bf
Zheng, Ming-Hua
9c79e9a5-730e-4bdf-85a8-9955ccfe7523
Lian, Li-You
a1293ae9-9f18-4c6e-bdea-d9831ca94887
Xia, Tianyi
b67c4fe9-9cf1-428e-8edc-7e68bba05a5b
Chen, Zhong-Wei
aa23fe30-344c-45cf-85c8-39295f8e33d7
Wen, Cai-Yun
650f63c3-64d7-4187-9967-95da95ca21b5
Zhou, Xiao-Dong
d36a40bb-d60d-4969-a319-60db45c19cc7
Xiao, Tie
d7fbb1ac-c12e-402d-ba7a-5ab27dac63d9
Targher, Giovanni
23ef21d8-f1cb-4a6a-baf4-b74acce04e91
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Yeo, Yee Hui
8f6198df-37e0-40a5-b44d-049c3f973ee3
Ju, Shenghong
2526c931-d6cb-4559-aac5-a27e965ebbee
Liu, Wen-Yue
1ef2663c-e732-499e-9ec8-2a014c1664bf
Zheng, Ming-Hua
9c79e9a5-730e-4bdf-85a8-9955ccfe7523

Lian, Li-You, Xia, Tianyi, Chen, Zhong-Wei, Wen, Cai-Yun, Zhou, Xiao-Dong, Xiao, Tie, Targher, Giovanni, Byrne, Christopher D., Yeo, Yee Hui, Ju, Shenghong, Liu, Wen-Yue and Zheng, Ming-Hua (2026) Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction. Liver International, 46 (3). (doi:10.1111/liv.70548).

Record type: Article

Abstract

Background & Aims: metabolic dysfunction-associated steatotic liver disease (MASLD) and pancreatic steatosis (PS) are interconnected ectopic fat conditions linked to cardiometabolic dysregulation. Their combined effect on the long-term risk of cardiometabolic multimorbidity (CMM; ≥ 2 of diabetes, hypertension, coronary heart disease, and stroke) and cardiac remodelling remains unclear.

Methods: we examined cross-sectional associations between PS and the severity of MASLD histology in a biopsy-proven MASLD cohort from China. Subsequently, using the UK Biobank, we assessed the long-term risk of developing both incident CMM and cardiac structural/functional alterations (via cardiac magnetic resonance [CMR]) associated with single-organ versus dual-organ steatosis. Exploratory proteomic profiling was performed to identify potential molecular pathways.

Results: in the biopsy-proven cohort (n = 482), both continuous pancreatic proton density fat fraction and PS status were associated with severe hepatic steatosis, lobular inflammation, and fibrosis (all p < 0.05). In the UK Biobank cohort (n = 16 408; median follow-up of 5.6 years), the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219–3.322, p = 0.006). Dual-organ steatosis was also associated with marked cardiac alterations, specifically increased left ventricular mass and impaired ventricular function. Proteomics revealed upregulation of lysosomal catabolic and glycosaminoglycan-degrading pathways in dual-organ steatosis compared to single-organ steatosis. Gene Ontology highlighted heparan sulphate proteoglycan catabolism as a hallmark of dual-organ involvement.

Conclusion: PS is associated with greater severity of MASLD histology, and the concomitant involvement of both the liver and pancreas drives a higher risk of CMM and cardiac remodelling.

Text
manuscript20260114 - Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy
Text
Supplemental Tables20260114 - Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy
Text
Figures - Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy

More information

Accepted/In Press date: 27 January 2026
e-pub ahead of print date: 14 February 2026

Identifiers

Local EPrints ID: 510052
URI: http://eprints.soton.ac.uk/id/eprint/510052
ISSN: 1478-3223
PURE UUID: 771c9d8f-e8e7-47e4-bfbd-a59868bcedde
ORCID for Christopher D. Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 16 Mar 2026 17:49
Last modified: 21 Mar 2026 02:41

Export record

Altmetrics

Contributors

Author: Li-You Lian
Author: Tianyi Xia
Author: Zhong-Wei Chen
Author: Cai-Yun Wen
Author: Xiao-Dong Zhou
Author: Tie Xiao
Author: Giovanni Targher
Author: Yee Hui Yeo
Author: Shenghong Ju
Author: Wen-Yue Liu
Author: Ming-Hua Zheng

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×